You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Harvard Business School
Johnson and Johnson
Dow
Moodys

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Misoprostol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for misoprostol and what is the scope of patent protection?

Misoprostol is the generic ingredient in two branded drugs marketed by Gd Searle Llc, Ani Pharms Inc, Novel Labs Inc, and Zydus Pharms, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for misoprostol. Sixteen suppliers are listed for this compound.

Drug Prices for misoprostol

See drug prices for misoprostol

Drug Sales Revenue Trends for misoprostol

See drug sales revenues for misoprostol

Recent Clinical Trials for misoprostol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Wisconsin, MadisonEarly Phase 1
Aljazeera HospitalEarly Phase 1
Suez Canal UniversityEarly Phase 1

See all misoprostol clinical trials

Pharmacology for misoprostol
Medical Subject Heading (MeSH) Categories for misoprostol

US Patents and Regulatory Information for misoprostol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc MISOPROSTOL misoprostol TABLET;ORAL 091667-002 Jul 25, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990 AB RX Yes No   Start Trial   Start Trial   Start Trial
Zydus Pharms MISOPROSTOL misoprostol TABLET;ORAL 210201-002 Jul 2, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc MISOPROSTOL misoprostol TABLET;ORAL 076095-002 Jul 10, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc MISOPROSTOL misoprostol TABLET;ORAL 076095-001 Jul 10, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for misoprostol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990   Start Trial   Start Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988   Start Trial   Start Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988   Start Trial   Start Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988   Start Trial   Start Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Baxter
Express Scripts
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.